Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniques, such as stereotactic radiofrequency lesions. While serendipity has played a role in developing DBS as a therapy, research during the past two decades has shown that electrical neuromodulation is far more than a functional lesion that can be switched on and off. This understanding broadens the field to enable new types of stimulation, clinical indications, and research. This review highlights the complex effects of DBS from the single cell to the neuronal network. Specifically, we examine the electrical, cellular, molecular, and neurochemical mechanisms of DBS as applied to Parkinson's disease and other emerging applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dalgleish, T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1432 · Cited by 1,849
Perlmutter, J. S., & Mink, J. W. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112824 · Cited by 1,073 · cited 1×
“Dopamine is a well-known therapeutic for treating movement disorders, such as PD, that are characterized by reduced dopamine production (Perlmutter & Mink, 2006).”
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · cited 6×
“Multiple targets such as the subgenual cingulate cortex (Brodmann Area 25, CG25; Holtzheimer et al, 2017), the NAcc (Bewernick et al, 2010; Fig 7A), the anterior limb of the internal capsule (ALIC; Bergfeld et al, 2016; Fig 7A), the medial forebrain bundle (Schlaepfer et al, 2013), and the lateral habenula (Sartorius…”
BackgroundInfluentialTranslational principles of deep brain stimulation
Kringelbach, M. L., Jenkinson, N., Owen, S. L. F., & Aziz, T. Z. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2196 · Cited by 853 · cited 3×
“…whole-brain changes, DBS of the right periventricular gray/periaqueductal gray (PVG/PAG) for treating phantom limb pain was shown to increase activity in a network, including subgenual cingulate and mid-anterior orbitofrontal cortex, associated with pain relief (Kringelbach et al, 2007a).”
BackgroundResultConnectivity Predicts deep brain stimulation outcome in Parkinson disease
Horn, A., Reich, M., Vorwerk, J., Li, N., Wenzel, G., Fang, Q., Schmitz‐Hübsch, T., Nickl, R., Kupsch, A., Volkmann, J., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24974 · Cited by 711
Probing and regulating dysfunctional circuits using deep brain stimulation
Lozano, A. M., & Lipsman, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.020 · Cited by 665
Self-citationTherapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease
de Hemptinne, C., Swann, N. C., Ostrem, J. L., Ryapolova-Webb, E. S., San Luciano, M., Galifianakis, N. B., & Starr, P. A. (2015) · Nature Neuroscience · doi:10.1038/nn.3997 · Cited by 623
Rapid effects of deep brain stimulation for treatment-resistant major depression
Schlaepfer, T. E., Bewernick, B. H., Kayser, S., Mädler, B., & Coenen, V. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.034 · Cited by 563 · cited 1×
“…NAcc (Bewernick et al, 2010; Fig 7A), the anterior limb of the internal capsule (ALIC; Bergfeld et al, 2016; Fig 7A), the medial forebrain bundle (Schlaepfer et al, 2013), and the lateral habenula (Sartorius et al, 2010) were investigated for treatment of MDD. DBS for treating OCD has been…”
BackgroundAxons, but not cell bodies, are activated by electrical stimulation in cortical gray matter
Nowak, L. G., & Bullier, J. (1998) · Experimental Brain Research · doi:10.1007/s002210050304 · Cited by 492
Network perspectives on the mechanisms of deep brain stimulation
McIntyre, C. C., & Hahn, P. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.022 · Cited by 439 · cited 2×
“Although the immediate effects of DBS are an altered firing pattern of neural circuits, these are often followed by changes in neurotransmitter dynamics and protein expression, which inevitably affect the behavior of the network in the longer term (McIntyre & Hahn, 2010; Fig 6).”
BackgroundStimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory
Stone, S. S. D., Teixeira, C. M., DeVito, L. M., Zaslavsky, K., Josselyn, S. A., Lozano, A. M., & Frankland, P. W. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3100-11.2011 · Cited by 384
Goodman, W. K., Foote, K. D., Greenberg, B. D., Ricciuti, N., Bauer, R., Ward, H., Shapira, N. A., Wu, S. S., Hill, C. L., Rasmussen, S. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.028 · Cited by 362
Mechanisms of action of deep brain stimulation (DBS)
Montgomery, E. B., & Gale, J. T. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.06.003 · Cited by 344
Bergfeld, I. O., Mantione, M., Hoogendoorn, M. L. C., Ruhé, H. G., Notten, P., van Laarhoven, J., Visser, I., Figee, M., de Kwaasteniet, B. P., Horst, F., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0152 · Cited by 336
Huff, W., Lenartz, D., Schormann, M., Lee, S.-H., Kuhn, J., Koulousakis, A., Mai, J., Daumann, J., Maarouf, M., Klosterkötter, J., et al. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.11.006 · Cited by 315 · cited 6×
“Multiple targets such as the subgenual cingulate cortex (Brodmann Area 25, CG25; Holtzheimer et al, 2017), the NAcc (Bewernick et al, 2010; Fig 7A), the anterior limb of the internal capsule (ALIC; Bergfeld et al, 2016; Fig 7A), the medial forebrain bundle (Schlaepfer et al, 2013), and the lateral habenula (Sartorius…”
MethodInfluentialOutcomes from stereotactic surgery for essential tremor
Dallapiazza, R. F., Lee, D. J., De Vloo, P., Fomenko, A., Hamani, C., Hodaie, M., Kalia, S. K., Fasano, A., & Lozano, A. M. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318240 · Cited by 233 · cited 2×
“In the case of essential tremor, DBS has shown to lead to 60– 75% long-term tremor control in more than 1,000 patients since 1998 (Dallapiazza et al, 2018).”
BackgroundInfluentialSelf-citationBoggio, P. S., Fregni, F., Bermpohl, F., Mansur, C. G., Rosa, M., Rumi, D. O., Barbosa, E. R., Odebrecht Rosa, M., Pascual‐Leone, A., Rigonatti, S. P., et al. (2005) · Movement Disorders · doi:10.1002/mds.20508 · Cited by 216
Herron, J. A., Thompson, M. C., Brown, T., Chizeck, H. J., Ojemann, J. G., & Ko, A. L. (2017) · Journal of Neurosurgery · doi:10.3171/2016.8.jns16536 · Cited by 139 · cited 1×
“This can include the power of beta oscillations in PD (Little et al, 2016) or accelerometer-detected amplitude in tremor (Herron et al, 2017).”
BackgroundTsukahara, T., Takeda, M., Shimohama, S., Ohara, O., & Hashimoto, N. (1995) · Neurosurgery · doi:10.1227/00006123-199510000-00018 · Cited by 134
Pienaar, I. S., Lee, C. H., Elson, J. L., McGuinness, L., Gentleman, S. M., Kalaria, R. N., & Dexter, D. T. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.006 · Cited by 125 · cited 3×
“…and increased expression of vascular endothelial growth factor (VEGF) and glial-derived neurotrophic factor (GDNF), led to the hypothesis that STN-DBS changes the microvasculature and causes sprouting of new more stables vessels compared to PD patients without DBS therapy (Pienaar et al, 2015).”
BackgroundResultInfluentialDifferential effects of transient and sustained activation of BDNF‐TrkB signaling
Guo, W., Nagappan, G., & Lu, B. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22592 · Cited by 111
Müller, U., Sturm, V., Voges, J., Heinze, H.-J., Galazky, I., Büntjen, L., Heldmann, M., Frodl, T., Steiner, J., & Bogerts, B. (2016) · Pharmacopsychiatry · doi:10.1055/s-0042-104507 · Cited by 108
Deep brain stimulation for chronic pain investigated with magnetoencephalography
Kringelbach, M. L., Jenkinson, N., Green, A. L., Owen, S. L. F., Hansen, P. C., Cornelissen, P. L., Holliday, I. E., Stein, J., & Aziz, T. Z. (2007) · NeuroReport · doi:10.1097/wnr.0b013e328010dc3d · Cited by 101
Clinical outcome and mechanisms of deep brain stimulation for obsessive-compulsive disorder
van Westen, M., Rietveld, E., Figee, M., & Denys, D. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0036-3 · Cited by 60 · cited 1×
“DBS therapy showed improvements of 47.7% in scores for 108 patients with obsessive– compulsive disorder and an overall responder rate (with a clinically meaningful reduction of 35% or more in the OCD score) of 58.2% (van Westen et al, 2015).”
BackgroundInfluentialLeong, S. L., De Ridder, D., Vanneste, S., Sutherland, W., Ross, S., & Manning, P. (2018) · Appetite · doi:10.1016/j.appet.2017.10.034 · Cited by 22
Cited by
Bach, P., Luderer, M., Müller, U. J., Jakobs, M., Baldermann, J. C., Voges, J., Kiening, K., Lux, A., Visser-Vandewalle, V., the DeBraSTRA study group, et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02337-1 · Cited by 65
Self-citation
Metadata
- Authors
- Jakobs, M., Fomenko, A., Lozano, A. M., & Kiening, K. L.
- Venue
- EMBO Molecular Medicine
- Published
- 2019-03-12
- Volume
- 11
- Issue
- 4
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2921116799
- Cited by
- 227
- References
- 25
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.